BRCA1 and BRCA2 Panel
A 2-gene panel for evaluating hereditary breast and ovarian cancer (HBOC) risk, powered by the Helix Exome+® platform for comprehensive BRCA1 and BRCA2 analysis.
6-21 days
≤ 5 days
Panel Description
This panel evaluates 2 genes associated with hereditary breast and ovarian cancer (HBOC).
Have Questions?
Our team is available Monday through Friday, 9am-5pm Pacific Time.
Indications for Testing
A relevant personal and/or family history suggestive of a hereditary form of cancer.
Methodology
This test utilizes next-generation sequencing to detect single nucleotide variants, insertions and deletions up to 20 bp, and copy number variants in genes associated with hereditary breast and ovarian cancer (HBOC).
Technical Specifications
> 99%
> 99%
> 99%
> 99%
> 90%
BRCA1: sequencing analysis extends to CDS +/-20 bp; BRCA2: analysis includes detection of c.156_157insAlu and sequencing analysis extends to CDS +/-20 bp....
GRCh38
Genes Tested
Showing 2 of 2 genes in this panel